1-4 of 4
Ana Marín-Niebla
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2 trial of the farnesyltransferase inhibitor tipifarnib for relapsed/refractory peripheral T-cell lymphoma

Clinical Trials & Observations
Thomas Witzig, Lubomir Sokol, Won Seog Kim, Fátima de la Cruz Vicente, Alejandro Martín García-Sancho, Ranjana Advani, Jose Maria Roncero Vidal, Raquel de Oña Navarrete, Ana Marín-Niebla, Antonia Rodriguez Izquierdo, María José Terol, Eva Domingo-Domenech, Andrew Saunders, Nawal Bendris, Julie Mackey, Mollie Leoni, Francine Foss
Journal: Blood Advances
Blood Adv (2024) 8 (17): 4581–4592.
https://doi.org/10.1182/bloodadvances.2024012806
Published: 2024
Includes: Supplemental data
Journal Articles

A gene expression assay based on chronic lymphocytic leukemia activation in the microenvironment to predict progression

Pau Abrisqueta, Daniel Medina, Guillermo Villacampa, Junyan Lu, Miguel Alcoceba, Julia Carabia, Joan Boix, Barbara Tazón-Vega, Gloria Iacoboni, Sabela Bobillo, Ana Marín-Niebla, Marcos González, Thorsten Zenz, Marta Crespo, Francesc Bosch
Journal: Blood Advances
Blood Adv (2022) 6 (21): 5763–5773.
https://doi.org/10.1182/bloodadvances.2022007508
Published: 2022
Includes: Supplemental data
Journal Articles

Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma

Gloria Iacoboni, Kai Rejeski, Guillermo Villacampa, Jaap A. van Doesum, Annalisa Chiappella, Francesca Bonifazi, Lucia Lopez-Corral, Michiel van Aalderen, Mi Kwon, Nuria Martínez-Cibrian, Stefania Bramanti, Juan Luis Reguera-Ortega, Lina Camacho-Arteaga, Christian Schmidt, Ana Marín-Niebla, Marie José Kersten, Alejandro Martin Garcia-Sancho, Pier Luigi Zinzani, Paolo Corradini, Tom van Meerten, Marion Subklewe, Pere Barba
Journal: Blood Advances
Blood Adv (2022) 6 (12): 3606–3610.
https://doi.org/10.1182/bloodadvances.2021006922
Published: 2022
Includes: Supplemental data
Journal Articles

Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies

Clinical Trials & Observations
Moraima Jiménez, Elisa Roldán, Candela Fernández-Naval, Guillermo Villacampa, Mónica Martinez-Gallo, Daniel Medina-Gil, Soraya Peralta-Garzón, Gemma Pujadas, Cristina Hernández, Carlota Pagès, Mercedes Gironella, Laura Fox, Guillermo Orti, Pere Barba, Tomás Pumarola, Alba Cabirta, Eva Catalá, Mercedes Valentín, Ana Marín-Niebla, Alberto Orfao, Marcos González, Magda Campins, Isabel Ruiz-Camps, David Valcárcel, Francesc Bosch, Manuel Hernández, Marta Crespo, Juliana Esperalba, Pau Abrisqueta
Journal: Blood Advances
Blood Adv (2022) 6 (3): 774–784.
https://doi.org/10.1182/bloodadvances.2021006101
Published: 2022
Includes: Supplemental data